Neodrop
Create
FeedDiscoverMy ChannelsAuto-publishJoin Our Discord
FeedDiscoverCreateMy Channels
Longevity Research Brief from Top Voices

Longevity Research Brief from Top Voices

Public
NeoDrop Official
NeoDrop Official

Weekly tracking of Peter Attia, David Sinclair, Bryan Johnson, Rhonda Patrick on longevity research, supplements, and protocols

Longevity Research Brief from Top Voices
Longevity Research Brief from Top Voices
2026-11-02

Longevity Digest, October 25–November 1: a 90% CTE figure, and the muscle that leaves in drops

In the week of October 25 – November 1, 2026: Peter Attia separates CTE's 90% figure from the risk most people carry and lays out the strength that disappears in drops, David Sinclair grades peptides by human evidence, Blueprint puts a whole-body MRI and a vaginal microbiome test on sale, and Rhonda Patrick traces light at night to a remodelled heart.

Longevity Research Brief from Top Voices
Longevity Research Brief from Top Voices
2026-10-26

Longevity Digest, October 18–25: a 42% lower risk of melanoma's return, and a fight over whether the field is real

In the week of October 18–25, 2026: a personalized mRNA cancer vaccine cut the risk of melanoma recurrence or death by 42% in a phase 3 trial, The Lancet called the longevity industry "a goldrush without gold" and David Sinclair answered it, Bryan Johnson explained why he skips coffee, and Rhonda Patrick traced a microplastics mechanism and audited an omega-3 death estimate.

Longevity Research Brief from Top Voices
Longevity Research Brief from Top Voices
2026-10-19

Longevity Digest, October 11–18: what Peter Attia no longer takes, and a phase 3 failure for NAD boosters

In the week of October 11–18, 2026: Peter Attia revisits eight years of his own positions, a phase 3 trial finds an NAD precursor left early Parkinson's symptoms slightly worse, Blueprint publishes a complete training week, and Sinclair reports OSK data from rats with liver disease.

Longevity Research Brief from Top Voices
Longevity Research Brief from Top Voices
2026-10-12

Longevity Digest, October 4–11: the first human readout from a reprogramming therapy, and what Alzheimer's drugs actually buy

In the week of October 4–11, 2026: the first human data from an epigenetic-reprogramming therapy tested in glaucoma, an accounting of what the decades-old Alzheimer's drugs actually buy, the blueberry dose that held up in a randomized trial, and a protein target two of the four voices shared.

Longevity Research Brief from Top Voices
Longevity Research Brief from Top Voices
2026-10-05

Longevity Digest, September 27–October 4: muscles that grow without strength, and a third more life for fast-aging mice

Attia's week on muscle drugs that add mass without strength and on early Alzheimer's prevention anchors a digest in which Rhonda Patrick argues against injecting unverified peptides, Blueprint writes up vitamin D, and Sinclair's lab reports a reprogramming result in fast-aging mice.

Longevity Research Brief from Top Voices
Longevity Research Brief from Top Voices
2026-09-28

Longevity Digest, September 20–27: the thyroid's gray zone, the order of interventions, and berries as a daily staple

Attia's thyroid deep-dive and his case for ordering interventions anchor a week in which three of the four tracked voices put ordinary practices ahead of compounds, while a berry protocol and a coffee correction show how to read the numbers behind a headline.

Longevity Research Brief from Top Voices
Longevity Research Brief from Top Voices
2026-09-21

Longevity Digest, September 13–20: a GLP-1 lifespan result in mice, the 8-gram LDL rule, and 14 dementia risk factors

Attia and Sinclair read the same semaglutide mouse study two different ways, Attia's guest makes the case for watching LDL from age 30, and Blueprint and Rhonda Patrick supply thresholds a reader can measure this week.

Longevity Research Brief from Top Voices
Longevity Research Brief from Top Voices
2026-09-14

Longevity Digest, September 6–13: outdoor light for myopia, protein floors, and growth hormone trade-offs

A weekly digest analyzing Peter Attia's review of outdoor light for myopia prevention, Rhonda Patrick's protein and fiber tracking, Blueprint's whole-food recipe, and David Sinclair's caution against growth hormone peptides.

Longevity Research Brief from Top Voices
Longevity Research Brief from Top Voices
2026-09-07

Longevity Digest, August 30–September 6: vaginal estrogen, eye protocols, and magnesium evidence

This week’s digest separates a clinician-facing vaginal-estrogen update, Blueprint’s practical eye-health habits, Rhonda Patrick’s magnesium caution, and David Sinclair’s research watch list.

Longevity Research Brief from Top Voices
Longevity Research Brief from Top Voices
2026-08-31

Longevity Digest, August 23-30: 200 F sauna, meditation in motion, and a female protocol

This week's digest separates a commercial sauna protocol, a female-protocol measurement plan, a meditation-in-movement practice, and a mouse-only resveratrol post so readers can judge what is actionable now.

Longevity Research Brief from Top Voices
Longevity Research Brief from Top Voices
2026-08-24

Longevity Digest — August 16–23, 2026: Brain-organoid time, sleep temperature, and oral-health prevention

This week’s digest separates a five-year brain-organoid research result from human protocols, and turns new advice on gum health, sleep temperature, collagen, zinc, protein, and exercise into bounded next steps.

Longevity Research Brief from Top Voices
Longevity Research Brief from Top Voices
2026-08-17

Longevity Digest — August 9–16, 2026: Peptides, postbiotics, and evidence boundaries

This week’s digest separates peptide hype from human evidence, labels Blueprint’s product-led protocol updates, and turns Patrick’s supplement and training posts into bounded actions rather than universal prescriptions.

View full content archive·Discover more channels